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To determine the population structure of the cryptococ-
cosis agents in China, we analyzed the genotype of 120 
Cryptococcus neoformans and 9 Cryptococcus gattii strains 
isolated from 1980 through 2006 from cryptococcosis pa-
tients residing in 16 provinces of mainland China. A total 
of 71% (91/129) of the clinical strains isolated from 1985 
through 2006 were from patients without any apparent risk 
factors. Only 8.5% (11/129) were from AIDS patients; the 
remaining 20.5% (27/129) were from patients with underly-
ing diseases other than HIV infection. One hundred twenty 
of the 129 isolates were C. neoformans serotype A, mating 
type MATα strains that exhibited an identical M13-based 
VNI subtype, which was distinguishable from the reference 
VNI molecular type. The 9 remaining isolates were sero-
type B, MATα strains of C. gattii and portrayed a typical VGI 
molecular type. Data analyzed from multilocus sequences 
showed no variation and that these Chinese C. neoformans 
isolates belong to a cluster that has phylogenetically di-
verged from the VNI reference strain. Our ﬁ  nding that most 
cryptococcosis patients in China had no apparent risk factor 
is in stark contrast with reports from other countries. 
C
ryptococcosis is caused by 2 species in the genus 
Cryptococcus,  C. neoformans and C. gattii ( 1).  C. 
neoformans (serotypes A, D, and AD) is found worldwide 
and causes cryptococcosis most frequently in AIDS pa-
tients (2,3). C. gattii (serotypes B and C) is geographically 
restricted and is infrequently diagnosed in AIDS patients 
except in some areas of Africa (4). The most widely used 
approaches for cryptococcal strain typing include the fol-
lowing: PCR ﬁ  ngerprint analysis based on microsatellite 
DNA using M13 primers (5,6) and (GACA)4 repeats (7), 
ampliﬁ  ed fragment length polymorphisms (8), sequence 
analysis of the rDNA intergenic spacer regions I and II 
(IGSI and IGSII) (9), and multilocus gene sequence typ-
ing (MLST) (10). These molecular approaches showed ge-
netically distinguishable subgroups for each serotype. For 
example, phylogenetic analysis of the IGS1-5.8S rDNA-
IGSII sequence showed 3 genotypes, 1a, 1b, and 1c, among 
the strains of serotype A collected worldwide (9). Likewise, 
PCR ﬁ  ngerprint patterns based on M13 microsatellite DNA 
identiﬁ  ed 2 major genotypes among the strains of serotype 
A. In this group, the VNI strain type was the most com-
mon genotype found worldwide (5). Furthermore, MLST 
showed 3 genetic subpopulations among strains of serotype 
A as well as subpopulations unique to certain geographic 
areas as was the case with strains from Botswana (VNB) 
in Africa (10). A C. neoformans genotype unique to Bo-
tswana showed epidemiologic importance of strain type. 
Rare genotypes of C. gattii have been reported from the 
recent outbreak of cryptococcosis on Vancouver Island in 
Canada (11). Finding C. gattii strains of a rare genotype in 
geographic areas outside of subtropical and tropical zones 
(12) further underscores the epidemiologic importance of 
this rare genotype.
In spite of extensive global strain typing, isolates from 
the People’s Republic of China have rarely been included 
(5,8,9). Recently, data released by the Chinese Department 
of Health indicated that by October 2006, the total number 
of HIV patients and those identiﬁ  ed as AIDS patients was 
183,733 and 40,667, respectively (www.chinacdc.net.cn/
n272442/n272530/n294176/n340510/15099.html).
From 1999 through 2006, a total of 224 articles on 
cryptococcosis have been published in Chinese journals; 
2,850 case-patients were included. We cited 6 representa-
tive reports from these papers (13–18). In these cases, only 
69 strains (0.2 %) were associated with AIDS. The popu-
Cryptococcus neoformans Strains 
and Infection in Apparently 
Immunocompetent Patients, China
Jianghan Chen,* Ashok Varma,†  Mara R. Diaz,‡  Anastasia P. Litvintseva,§ 
Kurt K. Wollenberg,† and Kyung J. Kwon-Chung†
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 5, May 2008  755 
*Shanghai Changzheng Hospital, Shanghai, People’s Republic of 
China; †National Institutes of Health, Bethesda, Maryland, USA; 
‡University of Miami, Miami, Florida, USA; and §Duke University 
Medical Center, Durham, North Carolina, USARESEARCH
lation structure of C. neoformans in China, however, has 
not been fully explored. In this study, we have used vari-
ous molecular typing approaches to analyze the population 
structure of the cryptococcosis agent in China. 
Materials and Methods
Cryptococcal Isolates
A total of 129 strains isolated from patients included 
120 C. neoformans and 9 C. gattii (online Appendix Table, 
available from www.cdc.gov/EID/content/14/5/755-appT.
htm). The identities of all strains were conﬁ  rmed according 
to routine diagnostic tests (2). L-canavanine-glycine-bro-
mothymol blue medium was used to differentiate the 2 spe-
cies (19). We used a set of strains representing the known 
molecular types within the 2 species as a reference: WM 
148 (serotype A, VNI), WM 626 (serotype A, VNII), Bt 
63 (serotype A, Botswana), WM 628 (serotype D, VNIII), 
WM629 (serotype AD, VNIV), WM 179 (serotype B, VGI), 
WM 178 (serotype B, VGII), WM 161 (serotype B, VGIII) 
and WM 779 (serotype C, VGIV)(6). The strain H99 (se-
rotype A) was also included (20). The isolates were stored 
in 25% glycerol at –80oC until use and were maintained on 
yeast peptone dextrose (1% yeast extract, 2% peptone, 2% 
glucose) agar at 25oC during this study.
Serotype and Mating Type
The CryptoCheck kit (Iatron, Tokyo, Japan) was used 
for serotyping. Mating type was determined by crossing 
all the C. neoformans strains with B-3501 (MATα) and 
JEC20 (MATa) and C. gattii strains with NIH112 (MATα) 
and NIH198 (MATa) on V-8 agar (11,21). A few strains 
of C. neoformans that showed ambiguous mating results 
were analyzed by PCR using serotype A MATα and MATa 
allele speciﬁ  c primers of either the STE12 or STE20 gene 
(22).Yeast cultures were grown overnight in yeast extract 
glucose broth (0.5% yeast extract, 2% glucose) at 30°C. 
Genomic DNA was extracted  from all strains as previously 
described (23).
Genotyping
Genotyping approaches included PCR and DNA se-
quencing. PCR ﬁ  ngerprint analysis was based on M13 prim-
ers for microsatellite DNA as well as primers containing 
sequence repeats of (GACA)4 and URA5–restriction frag-
ment length polymorphism (RFLP). Sequencing was per-
formed for partial IGSI-5.8S-IGSII region of rDNA cluster, 
and MLST involving 8 genes located on 7 different chro-
mosomes (10). PCR ﬁ  ngerprints using either the microsat-
ellite-speciﬁ  c primer M13 (5′-GAGGGTGGCGGTTCT-3′) 
(5) or the (GACA)4 sequence repeats (7) were generated  as 
described. The URA5-RFLP proﬁ  les were generated after 
digestion of the PCR fragment containing the URA5 gene 
sequence with Sau961 and Hha1 (6). IGSI sequence analy-
sis of the LrDNA gene was derived from PCR amplicon 
products (≈1.7 kb) generated by the primer pair combina-
tion LR11 (5′-TTACCACAGGGATAACTGGC-3′) and 
5SR (5′-GGATCGGACGGGGCAGGGTGC-3′) (9). The 
ampliﬁ  cation reactions were carried out in microtubes at 
a ﬁ  nal volume of 50 μL. The PCR mix contained 50–100 
ng of genomic DNA, 0.5 mmol/L of the forward and re-
verse primer pairs, 1.0 U DyNAzyme II polymerase, 1.5 
mmol/L MgCl2, and 200 mmol/L of each dNTP. The reac-
tion was performed in an MJ Research PTC-100 thermo-
cycler (GMI, Inc., Ramsey, MN, USA) and consisted of a 
denaturation step at 94°C for 1 min, followed by 40 cycles: 
2 min of denaturation at 95°C, 1 min of annealing at 57°C, 
and 3 min of extension at 72°C. A ﬁ  nal elongation step was 
conducted at 72°C for 7 min. The amplicon product was 
puriﬁ  ed with QIAquick PCR Puriﬁ  cation Kit (QIAGEN, 
Valencia, CA, USA). Amplicon synthesis was conﬁ  rmed 
by agarose gel electrophoresis. Sequencing reactions used 
the forward primer IGS1F (5′-CAG ACGACTTGAATG-
GGAACG-3′), located at positions 3613–3633 of the 
LrRNA region and the reverse primer IG2R (5′-ATG CAT 
AGA AAG CTG TTG G-3′), located at position 791 of the 
IGS1 region. Sequencing reactions were carried out with an 
ABI 3730 capillary sequencer (Applied Biosystems, Foster 
City, CA, USA) and followed the protocol described by 
Diaz et al. (9). Sequencing alignments of the IGS region 
were executed with MegAlign (DNASTAR, Inc., Madi-
son, WI, USA) and visually corrected. Phylogenetic tree 
construction used PAUP* version 4.0 (24) with parsimony 
analysis (heuristic search, stepwise addition, random ad-
dition sequence, nearest neighbor interchange, 100 maxi-
mum tree). Reliability of the character was checked by us-
ing bootstrap analysis with 500 replications.
Construction of Dendrogram Based on M13 RFLP
To construct a dendrogram based on M13-generated 
DNA  ﬁ   ngerprints, 12 strains representing the different 
provinces of China were chosen, along with 6 reference 
strains. The PCR product of the reference strain VNI was 
used twice in the panel (adjacent to the size marker and in 
the last lane). A total of 15 major bands that ranged in size 
from 3,054 bp to 506 bp were identiﬁ  ed across the lanes. 
Data were coded as 1 and 0; 1 represented the presence of 
a band and 0, its absence. This data matrix was coded into 
NEXUS format for input into the program PAUP* (24). 
PAUP* was used to generate a maximum parsimony phy-
logeny using a heuristic search algorithm. For the heuristic 
search, 10 random-addition replicates were performed. The 
starting tree for each replicate was obtained by stepwise 
addition. Seven replicates returned the same most parsimo-
nious tree, which had a tree score of 18 steps. To quantify 
clade robustness, 500 nonparametric bootstrap replicates 
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were performed. Bootstrap percentages >50% are indicat-
ed above the branches of the maximum parsimony phylo-
genetic tree. The tree ﬁ  gure for the maximum parsimony 
analysis was created using FigTree version 1.0 (http://tree.
bio.ed.ac.uk/software/ﬁ  gtree).
MLST
For MLST analysis, DNA fragments of 8 unlinked 
genes that included CAP10, GPD, IGS1, LAC1, PLB1, 
SOD1, TEF1, and URE1, were ampliﬁ  ed by PCR (10) from 
6 randomly chosen C. neoformans strains from China. DNA 
sequencing was carried out by using the dideoxy method, 
and sequences were compared with previously published se-
quences from the global collection of serotype A strains (10). 
To visualize the genetic relationships among different MLST 
genotypes, sequences were automatically aligned by using 
Sequencher 4.1 (Gene Codes Corp., Ann Arbor, MI, USA); 
the alignment was imported into MacClade 4.05 and edited 
manually. Because of the observed incongruence in the ge-
nealogies of several genes, combined sequence data for all 
88 worldwide isolates (10) were analyzed with the neighbor-
joining method using uncorrected (“p”) genetic distances. 
Statistical support for the phylogenetic groups was assessed 
by bootstrap analysis using 1,000 replicate data sets.
Virulence Study
Three Chinese strains of C. neoformans, CHC114, 
CHC186, and CHC193, were compared for their virulence 
in mice with 3 serotype A reference strains, H99, WM148 
(VNI), and WM626 (VNII). Ten 9-week old female 
BALB/c mice were infected intranasally with 5 × 107 cells 
of each strain (23) and were monitored for survival.
Results
The conditions of most patients (81.3%) were diag-
nosed at Shanghai Changzheng Hospital; the remaining 
patients (18.6%) were diagnosed at other hospitals. Pa-
tients without any recognizable predisposing factor for 
cryptococcosis such as HIV infection, malignancies, cir-
rhosis, organ transplantation, end-stage renal failure, auto-
immune disorder, diabetes mellitus, idiopathic CD4 T-cell 
lymphopenia, sarcoidosis, chronic usage of corticosteroids 
or other immunosuppressive therapies, and any abnormal 
symptoms were regarded as patients “without apparent risk 
factors” (2). Since 2002, the period when isolates were ob-
tained from 68% of the patients without apparent risk fac-
tors, HIV serologic testing and a battery of immunologic 
tests were performed on all cryptococcosis patients. Before 
2002, each patient’s cellular and humoral immune status 
was routinely determined. Any abnormality in these tests 
led to further HIV serology. The patients who had other-
wise normal test results were also subjected to HIV sero-
logic testing, the results of which were negative.
Of the 120 C. neoformans strains obtained from 16 
provinces located in the middle to the eastern regions of 
mainland China (Figure 1), 84 (70 %) strains were isolated 
from apparently healthy patients and 27 (22.5 %) strains 
were isolated from patients with risk factors other than HIV 
infection (online Appendix Table).  Only 9 (7.5 %) of the 
C. neoformans strains were isolated from AIDS patients. 
All 120 isolates were analyzed by PCR ﬁ  ngerprints using 
M13 primers, by URA5 RFLP patterns, and by (GACA)4 
sequence primers. Notably, all 120 strains of C. neoformans 
yielded an identical M13-based ﬁ  ngerprint pattern that could 
be distinguished from the reference types. In Figure 2, the 
M13 ﬁ  ngerprint patterns of 12 of the 120 strains are shown 
as examples along with the 6 reference strains. The major 
bands pattern for the serotype A isolates from China was 
more similar to the VNI than the other reference types (Fig-
ure 2, panel A). The URA5 RFLP (Figure 2, panel B) and 
(GACA)4 patterns of 120 isolates, however, were identical 
to that of the VNI type (online Appendix Figure 1, available 
from www.cdc.gov/EID/content/14/5/755-appG1.htm).
The phylogenetic tree for maximum parsimony anal-
ysis showed the strains to be closely related to the refer-
ence strain VNI and the H99 strain (Figure 3). The H99 
strain had the same M13 ﬁ  ngerprint pattern as that of the 
VNI strain. Genotyping by sequence analysis of the IGSI- 
rDNA region indicated that the C. neoformans strains from 
China  belonged to the C. neoformans genotype 1a (on-
line Appendix Figure 2, available from www.cdc.gov/EID/
content/14/5/755-appG2.htm). Genotype 1a is the major 
genotype found among the serotype A strains of C. neofor-
mans collected worldwide and follows a clonal pattern (9).
MLST, performed using 8 unlinked genes from 6 
randomly chosen strains, showed identical sequences for 
the CAP10, GPD, LAC1, PLB1, SOD1, IGSI, TEF1, and 
URE1 genes. These results corroborate the homogeneity 
observed with various PCR ﬁ  ngerprint patterns. Notably, 
the Chinese strains of C. neoformans formed a cluster 
with 7 strains previously reported by Litvintseva et al. 
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Figure 1. Mainland China. The numbers in parentheses represent 
strains used in this study that were isolated during 1980–2006 from 
each region.RESEARCH
(Table) (10) and formed a distinct cluster, M5, that ap-
peared to have diverged from the M1 genotype to which 
the VNI reference strain belongs (Figure 4). Two strains 
in the M5 that clustered with the Chinese strains, jp1086 
and jp1088, were isolated in Japan and the M-13 ﬁ  nger-
print pattern of all 7 strains (Table) tested was identical 
to that of the Chinese strains (online Appendix Figure 
3, available from www.cdc.gov/EID/content/14/5/755-
appG3.htm). Our genotyping data indicates that M13-based 
PCR ﬁ  ngerprinting together with the MLST are powerful 
tools that enable discrimination of different strain types. 
The 3 Chinese C. neoformans strains randomly chosen to 
assess virulence were considerably less virulent than the 
H99 strain and moderately to signiﬁ  cantly more virulent 
than VNI and VNII reference strains (Figure 5).
The H99 strain, the type strain of C. neoformans var. 
grubii (26), clustered with VNI strain based on the MLST 
data. The previous MLST tree, which did not place the H99 
strain in the same cluster, A1 + A3 (= M1), as VNI was 
determined to be due to an error introduced during the se-
quencing process (10). The sequences from 8 genes that 
we sequenced matched 100% with the nucleotide sequence 
data posted in the H99 genomic database.
Nine isolates of C. gattii were all obtained from the 
eastern regions of China. Except for 1 strain from Shang-
dong, and 1 from Shanghai, all strains were recovered from 
provinces located south of Shanghai with a warm climate. 
Five (55%) of the 9 strains of C. gattii were from the Zheji-
ang province where Eucalyptus trees are commonly found. 
Of the 9 C. gattii strains, 2 were isolated from AIDS pa-
tients and 7 were isolated from otherwise normal patients. 
All of the C. gattii strains were serotype B, of MATα mating 
type with typical PCR patterns of the VGI type (Figure 6). 
IGS sequences from 4 randomly chosen strains belonged to 
the genotype 4b (9).
Discussion
From 1985 to 2007, a total of 7,372 cases of cryptococ-
cosis were reported in China. However, documentation on 
these patients is mostly unavailable, and fragmented docu-
mentation is available for only 1,999 cases. Among them, 
323 (16.2%) cases seem to have occurred in patients with 
no underlying disease and who were considered otherwise 
healthy; 215 (10.8%) cases occurred in AIDS patients (Z. 
Yao et al., unpub. data).
This study provides a large scale population analysis 
of C. neoformans strains isolated from 129 patients with 
well-documented clinical cases of cryptococcosis that were 
treated at the Shanhai Changzheng Hospital. All patients 
were assessed for the common predisposing factors for 
cryptococcosis. Patients without any of these predispos-
ing factors were regarded as “with no apparent risk fac-
tor.” HIV serology was performed for all cases that have 
occurred since 2002. A total of 68% (56/82) of the patients 
had no underlying disease. Patient outcomes were moni-
tored for 2 years following treatment at which time patients 
were determined to be cured of cryptococcosis.
Consistent with previous reports, all 120 clinical strains 
of C. neoformans isolated from China were serotype A and 
MATα (2). In contrast to the genotypic diversity of clinical 
C. neoformans serotype A strains found in other countries, 
such as Brazil, Australia, and the United States (5,27), the 
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Table. Information on 7 Cryptococcus neoformans strains previously determined as M5 of MLST* 
Strain  Geographic origin  Source  MAT  Year  MLST type  VN type   Reference 
Jt743 Italy  Unknown  Į  Unknown  M5  VNI S.  Maesaki 
Jp1086 Japan  Human  lung  Į  1999  M5  VNI S.  Maesaki 
Jp1088 Japan  Human  lung  Į  1999  M5  VNI (10) 
mal 212 i  Malawi  CSF  Į  1999  Ȃ5  VNI (25) 
C48 USA  Bronchial  lavage  Į  2001  Ȃ5  VNI   (10) 
C8 USA  CSF  Į  2001  Ȃ5  VNI (10) 
A5 36–17  USA  Pigeon excreta  Į  2002  Ȃ5  VNI (10) 
*MLST, multilocus sequence typing; MAT, mating type; CSF, cerebrospinal fluid. 
Figure 2. DNA ﬁ  ngerprint patterns of 12 Cryptococcus neoformans 
strains from China and the molecular type reference strains. A) 
M13-based PCR pattern. B) URA5 restriction fragment-length 
polymorphism. Lanes: 1, VNI; 2–12, 11 Chinese strains; 13, H99; 
14, Chinese strain B-4587; 15, VNBt63; 16, VNI; 17, VNIII; 18, 
VNII; 19, VNI; 20, marker.Cryptococcal neoformans Strains, China
Chinese C. neoformans strains showed remarkable genetic 
homogeneity. This was evident not only in the patterns 
based on various PCR ﬁ  ngerprints but also by the lack of 
diversity in MLST results. A report from India also showed 
relatively low genetic diversity among 57 clinical C. neo-
formans isolates. However, a serotype D strain was found, 
indicating that the population structure of C. neoformans in 
India is less homogeneous than that in China (28). Remark-
ably, a majority of the Chinese strains caused cryptococ-
cosis in persons without any recognizable immune defect 
or underlying disease. Although a considerable number of 
AIDS patients have been identiﬁ  ed, 8.5% of the 129 strains 
isolated across mainland China were recovered from AIDS 
patients; 71% were isolated from otherwise healthy per-
sons. This is in stark contrast to the >80% AIDS-associated 
cryptococcosis cases reported in Europe and the United 
States and the 69% reported in Africa (29–31). Although 
markedly lower than the frequency in China, a relatively 
high number of cases of non-AIDS associated cryptococ-
cosis due to C. neoformans were documented in Australia, 
New Zealand (32), and India (28). Most patients in Austra-
lia and New Zealand, however, were immunocompromised 
(32). The report from India showed that 41% of the cryp-
tococcosis patients also had HIV infections; the remaining 
patients were determined to have no known immune defect 
(28). Information on the underlying diseases in these HIV-
free Indian patients, however, was not recorded.
We recognize the possibility that 71% of the Chinese 
cryptococcosis patients without apparent underlying dis-
ease may have had subtle defects in immunity that may 
have predisposed them to cryptococcosis. Alternatively, 
genetic factors may play an important role in the unusu-
ally high non–AIDS-associated cryptococcosis in China. 
A relationship between common functional genetic poly-
morphisms of the low-afﬁ  nity Fc gamma receptor genes, 
FCGR2A, -3A, and -3B, and the risk of cryptococcosis 
in HIV-uninfected patients was recently reported (33). It 
would be of interest to investigate the relationship between 
the genetic polymorphisms of the 3 genes in the immuno-
competent Chinese cryptococcocis patients.
The M13 based PCR ﬁ  ngerprints of the Chinese C. 
neoformans strains were identical to each other and similar 
but distinguishable from VNI.  For convenience throughout 
the discussion, we will hereafter refer to the M13 pattern of 
the Chinese strains as VNIc. The MLST-based phylogenet-
ic tree also showed that the VNIc diverged from WM148 
and formed a separate cluster with 7 previously analyzed 
strains (10). The 7 strains that cluster with the VNIc strains 
had originated from 3 different continents, which suggests 
that the VNIc type is not unique to China and apparently 
follows a widespread cosmopolitan distribution. We found 
that the 7 strains that cluster with Chinese strains have ex-
actly the same M13 PCR pattern as the VNIc type. Whether 
most of these 8 strains were also from immunocompetent 
patients is not known. Since analysis of the IGSI region of 
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Figure 3. The phylogenetic tree for maximum parsimony analysis 
composed on the basis of the M13-based PCR pattern of 12 
Chinese Cryptococcus neoformans strains. Numbers above the 
branches represent bootstrap support percentages based on 500 
replicates. The scale bar represents the inferred number of steps 
along a branch of the tree.
Figure 4. Genetic relationship of multilocus sequence typing (MLST) 
genotypes among 94 isolates of Cryptococcus neoformans serotype 
A (88 strains from Litvintseva et al. [10]) and 6 representative Chinese 
strains) visualized by the neighbor-joining dendrogram. Numbers 
on each branch indicate the bootstrap values >50%, based on 500 
replicates. Vertical lines represent strains with identical genotypes. 
Arrows indicate MLST results for Chinese strains.RESEARCH
the VNIc strains showed it to be identical with WM148, 
the M13 ﬁ  ngerprint analysis appears to have greater dis-
criminatory power in distinguishing the VNIc strains from 
the typical VNI type than IGSI analysis. The URA5 RFLP 
analysis or the (GACA)4-based PCR ﬁ  ngerprints also had 
lower resolution power than the M13 pattern analysis be-
cause the 2 methods could not distinguish VNIc from the 
WM148 strain.
We do not know if VNIc is the most common type 
in China because the present study only analyzed clini-
cal strains. Environmental strains should also be isolated 
and undergo molecular typing. Such a study would offer 
insight into the importance of the VNIc strain type in rela-
tion to infection in otherwise healthy persons in China. In 
general, the occurrence of cryptococcosis in patients with-
out any apparent immune defect or underlying disease is 
relatively rare (2,34). In the United States, the incidence of 
cryptococcosis in immunocompetent patients has been es-
timated at 0.2/1,000,000 population per year in California 
(35); 0.9/100,000 in Atlanta, Georgia; and 0.93/100,000 in 
Alabama (36).
The presence of the VGI type in China is not surprising 
because it is the most common C. gattii strain type identi-
ﬁ  ed in Southeast Asia and most of the C. gattii strains ob-
tained were from the southeastern part of China. Although 
the total number of the C. gattii strains studied is small, the 
percentage of AIDS-associated C. gattii infections in China 
is higher than expected. Other than from certain geographic 
areas in Africa (4), C. gattii strains are rarely isolated from 
AIDS patients (2,32). In Australia where C. gattii is preva-
lent, for example, only 1 of 47 clinical strains of C. gattii 
was isolated from a patient with AIDS (32).
In our previous study, the urease-negative strain 
B-4578, which had been isolated from a cryptococcosis pa-
tient in China, was as virulent in mice as was the highly vir-
ulent H99 strain (23). Because the strain B-4578 was also 
of the VNIc molecular type, it was tempting to assume that 
strains isolated from immunocompetent patients in China 
would similarly be highly virulent in experimental animals. 
Indeed, the 3 strains of the VNIc type isolated from differ-
ent provinces tested in mice were more virulent than the 
VNI reference strain. However, they were considerably 
less virulent than the H99 strain, which had been isolated 
from an immunocompromised patient (20). This suggests 
that a wide variation in virulence exists among the strains 
of the VNIc molecular type. Whether the degree of crypto-
coccal strain virulence manifested in mice is comparable 
to the human host remains unknown. Our experience with 
strain NIH12 has shown that virulence in mice does not 
necessarily correlate with that of the human host. The strain 
NIH12 is one of the most virulent serotype D strains tested 
in BALB/c mice (37); it only caused a chronic localized 
infection without dissemination in the human host. The 
patient infected by the NIH12 strain had sarcoidosis and 
a chronic, localized, osteomyelitis lesion later developed 
in the hip, which was cured by amphotericin B treatment 
without any dissemination or recurrence.
Because all 129 of the cryptococcal strains were 
isolated from Chinese, primarily immunocompetent, pa-
tients, one can ask whether any susceptibility difference 
to cryptococcosis is related to ethnicity. Australian stud-
ies have indicated a higher frequency of cryptococcosis 
in Aborigines (38) than in whites, and in Los Angeles, 
disease incidence was reported to be twice as frequent in 
Hispanics than in whites (39). However, data regarding 
ethnic differences in susceptibilities are scant and uncon-
vincing. Since most of the 129 strains were isolated from 
non-AIDS patients in China, possible differences may ex-
ist in the reporting systems for cryptococcosis cases among 
AIDS patients and among non-AIDS patients. While some 
strains were isolated from patients in Henen, Yunan, and 
Xinjian provinces where HIV/AIDS was more prevalent, 
most strains were from patients in regions where HIV/
AIDS was not prevalent. Although the HIV status of some 
otherwise apparently healthy patients was unknown, they 
did fully recover after antifungal treatment. The outcome 
of the AIDS patients with cryptococcosis, however, is un-
known because they were transferred to a quarantined fa-
760  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 5, May 2008
Figure 5. Virulence in mice. Mice 
were intranasally infected with 5 × 107 
yeast cells from the 3 Cryptococcus 
neoformans Chinese strains, CHC114, 
CHC193, and CHC 186, and compared 
with H99 and the reference strains 
VNI and VNII for survival.Cryptococcal neoformans Strains, China
cility soon after they were diagnosed to be HIV positive. 
To determine whether Chinese AIDS patients are more 
resistant to cryptococcosis than AIDS patients in other 
countries, differences in how AIDS patients are handled 
in China should be investigated.
In conclusion, this study reveals a strikingly homo-
geneous cryptococcal population belonging to a subtype 
of VNI in China. The high incidence of cryptococcosis in 
immunocompetent patients in China contrasts with reports 
from other countries.
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etymologia etymologia
Cryptococcus neoformans
[krip´´ to-kok´əs ne´´o for-mənz], from the Greek—krypto (hidden), 
kokkos (berry), neos (new); and Latin—forma (form)
C. neoformans is an encapsulated yeastlike fungus of the family Cryptococcaceae. It was ﬁ  rst described in 1894 by 
German pathologist Otto Busse, who observed the cells in a tumor from the tibia of a woman with sarcoma. Found 
worldwide in nests and droppings of pigeons, it is the most common species that causes cryptococcosis in humans. 
The effects range from asymptomatic infection to meningitis, pneumonia, or disseminated disease. The crucial 
factor is the immune status of the host. With the global emergence of AIDS, the incidence of cryptococcosis is 
increasing and now represents a major life-threatening infection in these patients.
Sources:  Dorland’s Illustrated Medical Dictionary, 31st edition. Philadelphia: Saunders Elsevier; 2007; http://www.emedicine.com/
med/TOPIC482.HTM